Global AI Pharma Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for AI Pharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Pharma.
The AI Pharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global AI Pharma market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Pharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Pharma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The AI Pharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global AI Pharma market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Pharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Recursion
- Insilico Medicine
- Exscientia
- BenevolentAI
- Atomwise
- Roivant Sciences
- Schrцdinger
- Lantern Pharma
- XtalPi
- Landos Biopharma
- Relay Therapeutics
- Accutar Biotech
- Deep Genomics
- Oncocross
- AI Therapeutics
- BioMap
- METiS Pharmaceuticals
- NeoX Biotech
- StoneWise
- Deep Intelligent Pharma
- Gigaceuticals
- Chemical.AI
- Artivila
- Galixir
- Xbiome
- Self-developed Oipeline
- Contract Research Organization (CRO)
- Other
- Preclinical Stage (Optimization of Lead Compounds, etc.)
- Clinical Trial Phase (Predicting Treatment Outcome, etc.)
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Pharma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 DPU G.Fast Chipset Product Introduction
1.2 Market by Type
1.2.1 Global DPU G.Fast Chipset Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Lines Shorter Than 100 Meters
1.2.3 Lines of 100 Meters–150 Meters
1.2.4 Lines of 150 Meters–200 Meters
1.2.5 Lines of 200 Meters–250 Meters
1.2.6 Lines Longer Than 250 Meters
1.3 Market by Application
1.3.1 Global DPU G.Fast Chipset Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Residential
1.3.3 Commercial/Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL DPU G.FAST CHIPSET PRODUCTION
2.1 Global DPU G.Fast Chipset Production Capacity (2018-2029)
2.2 Global DPU G.Fast Chipset Production by Region: 2018 VS 2022 VS 2029
2.3 Global DPU G.Fast Chipset Production by Region
2.3.1 Global DPU G.Fast Chipset Historic Production by Region (2018-2023)
2.3.2 Global DPU G.Fast Chipset Forecasted Production by Region (2024-2029)
2.3.3 Global DPU G.Fast Chipset Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 South Korea
3 EXECUTIVE SUMMARY
3.1 Global DPU G.Fast Chipset Revenue Estimates and Forecasts 2018-2029
3.2 Global DPU G.Fast Chipset Revenue by Region
3.2.1 Global DPU G.Fast Chipset Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global DPU G.Fast Chipset Revenue by Region (2018-2023)
3.2.3 Global DPU G.Fast Chipset Revenue by Region (2024-2029)
3.2.4 Global DPU G.Fast Chipset Revenue Market Share by Region (2018-2029)
3.3 Global DPU G.Fast Chipset Sales Estimates and Forecasts 2018-2029
3.4 Global DPU G.Fast Chipset Sales by Region
3.4.1 Global DPU G.Fast Chipset Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global DPU G.Fast Chipset Sales by Region (2018-2023)
3.4.3 Global DPU G.Fast Chipset Sales by Region (2024-2029)
3.4.4 Global DPU G.Fast Chipset Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 COMPETITION BY MANUFACTURES
4.1 Global DPU G.Fast Chipset Sales by Manufacturers
4.1.1 Global DPU G.Fast Chipset Sales by Manufacturers (2018-2023)
4.1.2 Global DPU G.Fast Chipset Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of DPU G.Fast Chipset in 2022
4.2 Global DPU G.Fast Chipset Revenue by Manufacturers
4.2.1 Global DPU G.Fast Chipset Revenue by Manufacturers (2018-2023)
4.2.2 Global DPU G.Fast Chipset Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by DPU G.Fast Chipset Revenue in 2022
4.3 Global DPU G.Fast Chipset Sales Price by Manufacturers
4.4 Global Key Players of DPU G.Fast Chipset, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global DPU G.Fast Chipset Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of DPU G.Fast Chipset, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of DPU G.Fast Chipset, Product Offered and Application
4.8 Global Key Manufacturers of DPU G.Fast Chipset, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 MARKET SIZE BY TYPE
5.1 Global DPU G.Fast Chipset Sales by Type
5.1.1 Global DPU G.Fast Chipset Historical Sales by Type (2018-2023)
5.1.2 Global DPU G.Fast Chipset Forecasted Sales by Type (2024-2029)
5.1.3 Global DPU G.Fast Chipset Sales Market Share by Type (2018-2029)
5.2 Global DPU G.Fast Chipset Revenue by Type
5.2.1 Global DPU G.Fast Chipset Historical Revenue by Type (2018-2023)
5.2.2 Global DPU G.Fast Chipset Forecasted Revenue by Type (2024-2029)
5.2.3 Global DPU G.Fast Chipset Revenue Market Share by Type (2018-2029)
5.3 Global DPU G.Fast Chipset Price by Type
5.3.1 Global DPU G.Fast Chipset Price by Type (2018-2023)
5.3.2 Global DPU G.Fast Chipset Price Forecast by Type (2024-2029)
6 MARKET SIZE BY APPLICATION
6.1 Global DPU G.Fast Chipset Sales by Application
6.1.1 Global DPU G.Fast Chipset Historical Sales by Application (2018-2023)
6.1.2 Global DPU G.Fast Chipset Forecasted Sales by Application (2024-2029)
6.1.3 Global DPU G.Fast Chipset Sales Market Share by Application (2018-2029)
6.2 Global DPU G.Fast Chipset Revenue by Application
6.2.1 Global DPU G.Fast Chipset Historical Revenue by Application (2018-2023)
6.2.2 Global DPU G.Fast Chipset Forecasted Revenue by Application (2024-2029)
6.2.3 Global DPU G.Fast Chipset Revenue Market Share by Application (2018-2029)
6.3 Global DPU G.Fast Chipset Price by Application
6.3.1 Global DPU G.Fast Chipset Price by Application (2018-2023)
6.3.2 Global DPU G.Fast Chipset Price Forecast by Application (2024-2029)
7 US & CANADA
7.1 US & Canada DPU G.Fast Chipset Market Size by Type
7.1.1 US & Canada DPU G.Fast Chipset Sales by Type (2018-2029)
7.1.2 US & Canada DPU G.Fast Chipset Revenue by Type (2018-2029)
7.2 US & Canada DPU G.Fast Chipset Market Size by Application
7.2.1 US & Canada DPU G.Fast Chipset Sales by Application (2018-2029)
7.2.2 US & Canada DPU G.Fast Chipset Revenue by Application (2018-2029)
7.3 US & Canada DPU G.Fast Chipset Sales by Country
7.3.1 US & Canada DPU G.Fast Chipset Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada DPU G.Fast Chipset Sales by Country (2018-2029)
7.3.3 US & Canada DPU G.Fast Chipset Revenue by Country (2018-2029)
7.3.4 U.S.
7.3.5 Canada
8 EUROPE
8.1 Europe DPU G.Fast Chipset Market Size by Type
8.1.1 Europe DPU G.Fast Chipset Sales by Type (2018-2029)
8.1.2 Europe DPU G.Fast Chipset Revenue by Type (2018-2029)
8.2 Europe DPU G.Fast Chipset Market Size by Application
8.2.1 Europe DPU G.Fast Chipset Sales by Application (2018-2029)
8.2.2 Europe DPU G.Fast Chipset Revenue by Application (2018-2029)
8.3 Europe DPU G.Fast Chipset Sales by Country
8.3.1 Europe DPU G.Fast Chipset Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe DPU G.Fast Chipset Sales by Country (2018-2029)
8.3.3 Europe DPU G.Fast Chipset Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 CHINA
9.1 China DPU G.Fast Chipset Market Size by Type
9.1.1 China DPU G.Fast Chipset Sales by Type (2018-2029)
9.1.2 China DPU G.Fast Chipset Revenue by Type (2018-2029)
9.2 China DPU G.Fast Chipset Market Size by Application
9.2.1 China DPU G.Fast Chipset Sales by Application (2018-2029)
9.2.2 China DPU G.Fast Chipset Revenue by Application (2018-2029)
10 ASIA (EXCLUDING CHINA)
10.1 Asia DPU G.Fast Chipset Market Size by Type
10.1.1 Asia DPU G.Fast Chipset Sales by Type (2018-2029)
10.1.2 Asia DPU G.Fast Chipset Revenue by Type (2018-2029)
10.2 Asia DPU G.Fast Chipset Market Size by Application
10.2.1 Asia DPU G.Fast Chipset Sales by Application (2018-2029)
10.2.2 Asia DPU G.Fast Chipset Revenue by Application (2018-2029)
10.3 Asia DPU G.Fast Chipset Sales by Region
10.3.1 Asia DPU G.Fast Chipset Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia DPU G.Fast Chipset Revenue by Region (2018-2029)
10.3.3 Asia DPU G.Fast Chipset Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 MIDDLE EAST, AFRICA AND LATIN AMERICA
11.1 Middle East, Africa and Latin America DPU G.Fast Chipset Market Size by Type
11.1.1 Middle East, Africa and Latin America DPU G.Fast Chipset Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America DPU G.Fast Chipset Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America DPU G.Fast Chipset Market Size by Application
11.2.1 Middle East, Africa and Latin America DPU G.Fast Chipset Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America DPU G.Fast Chipset Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America DPU G.Fast Chipset Sales by Country
11.3.1 Middle East, Africa and Latin America DPU G.Fast Chipset Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America DPU G.Fast Chipset Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America DPU G.Fast Chipset Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 CORPORATE PROFILES
12.1 Broadcom(US)
12.1.1 Broadcom(US) Company Information
12.1.2 Broadcom(US) Overview
12.1.3 Broadcom(US) DPU G.Fast Chipset Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Broadcom(US) DPU G.Fast Chipset Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Broadcom(US) Recent Developments
12.2 Sckipio Technology(Israel)
12.2.1 Sckipio Technology(Israel) Company Information
12.2.2 Sckipio Technology(Israel) Overview
12.2.3 Sckipio Technology(Israel) DPU G.Fast Chipset Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Sckipio Technology(Israel) DPU G.Fast Chipset Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Sckipio Technology(Israel) Recent Developments
12.3 Metanoia Communication(Taiwan)
12.3.1 Metanoia Communication(Taiwan) Company Information
12.3.2 Metanoia Communication(Taiwan) Overview
12.3.3 Metanoia Communication(Taiwan) DPU G.Fast Chipset Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Metanoia Communication(Taiwan) DPU G.Fast Chipset Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Metanoia Communication(Taiwan) Recent Developments
12.4 Qualcomm(US)
12.4.1 Qualcomm(US) Company Information
12.4.2 Qualcomm(US) Overview
12.4.3 Qualcomm(US) DPU G.Fast Chipset Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Qualcomm(US) DPU G.Fast Chipset Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Qualcomm(US) Recent Developments
13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
13.1 DPU G.Fast Chipset Industry Chain Analysis
13.2 DPU G.Fast Chipset Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 DPU G.Fast Chipset Production Mode & Process
13.4 DPU G.Fast Chipset Sales and Marketing
13.4.1 DPU G.Fast Chipset Sales Channels
13.4.2 DPU G.Fast Chipset Distributors
13.5 DPU G.Fast Chipset Customers
14 DPU G.FAST CHIPSET MARKET DYNAMICS
14.1 DPU G.Fast Chipset Industry Trends
14.2 DPU G.Fast Chipset Market Drivers
14.3 DPU G.Fast Chipset Market Challenges
14.4 DPU G.Fast Chipset Market Restraints
15 KEY FINDING IN THE GLOBAL DPU G.FAST CHIPSET STUDY
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1.1 DPU G.Fast Chipset Product Introduction
1.2 Market by Type
1.2.1 Global DPU G.Fast Chipset Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Lines Shorter Than 100 Meters
1.2.3 Lines of 100 Meters–150 Meters
1.2.4 Lines of 150 Meters–200 Meters
1.2.5 Lines of 200 Meters–250 Meters
1.2.6 Lines Longer Than 250 Meters
1.3 Market by Application
1.3.1 Global DPU G.Fast Chipset Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Residential
1.3.3 Commercial/Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL DPU G.FAST CHIPSET PRODUCTION
2.1 Global DPU G.Fast Chipset Production Capacity (2018-2029)
2.2 Global DPU G.Fast Chipset Production by Region: 2018 VS 2022 VS 2029
2.3 Global DPU G.Fast Chipset Production by Region
2.3.1 Global DPU G.Fast Chipset Historic Production by Region (2018-2023)
2.3.2 Global DPU G.Fast Chipset Forecasted Production by Region (2024-2029)
2.3.3 Global DPU G.Fast Chipset Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 South Korea
3 EXECUTIVE SUMMARY
3.1 Global DPU G.Fast Chipset Revenue Estimates and Forecasts 2018-2029
3.2 Global DPU G.Fast Chipset Revenue by Region
3.2.1 Global DPU G.Fast Chipset Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global DPU G.Fast Chipset Revenue by Region (2018-2023)
3.2.3 Global DPU G.Fast Chipset Revenue by Region (2024-2029)
3.2.4 Global DPU G.Fast Chipset Revenue Market Share by Region (2018-2029)
3.3 Global DPU G.Fast Chipset Sales Estimates and Forecasts 2018-2029
3.4 Global DPU G.Fast Chipset Sales by Region
3.4.1 Global DPU G.Fast Chipset Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global DPU G.Fast Chipset Sales by Region (2018-2023)
3.4.3 Global DPU G.Fast Chipset Sales by Region (2024-2029)
3.4.4 Global DPU G.Fast Chipset Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 COMPETITION BY MANUFACTURES
4.1 Global DPU G.Fast Chipset Sales by Manufacturers
4.1.1 Global DPU G.Fast Chipset Sales by Manufacturers (2018-2023)
4.1.2 Global DPU G.Fast Chipset Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of DPU G.Fast Chipset in 2022
4.2 Global DPU G.Fast Chipset Revenue by Manufacturers
4.2.1 Global DPU G.Fast Chipset Revenue by Manufacturers (2018-2023)
4.2.2 Global DPU G.Fast Chipset Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by DPU G.Fast Chipset Revenue in 2022
4.3 Global DPU G.Fast Chipset Sales Price by Manufacturers
4.4 Global Key Players of DPU G.Fast Chipset, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global DPU G.Fast Chipset Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of DPU G.Fast Chipset, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of DPU G.Fast Chipset, Product Offered and Application
4.8 Global Key Manufacturers of DPU G.Fast Chipset, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 MARKET SIZE BY TYPE
5.1 Global DPU G.Fast Chipset Sales by Type
5.1.1 Global DPU G.Fast Chipset Historical Sales by Type (2018-2023)
5.1.2 Global DPU G.Fast Chipset Forecasted Sales by Type (2024-2029)
5.1.3 Global DPU G.Fast Chipset Sales Market Share by Type (2018-2029)
5.2 Global DPU G.Fast Chipset Revenue by Type
5.2.1 Global DPU G.Fast Chipset Historical Revenue by Type (2018-2023)
5.2.2 Global DPU G.Fast Chipset Forecasted Revenue by Type (2024-2029)
5.2.3 Global DPU G.Fast Chipset Revenue Market Share by Type (2018-2029)
5.3 Global DPU G.Fast Chipset Price by Type
5.3.1 Global DPU G.Fast Chipset Price by Type (2018-2023)
5.3.2 Global DPU G.Fast Chipset Price Forecast by Type (2024-2029)
6 MARKET SIZE BY APPLICATION
6.1 Global DPU G.Fast Chipset Sales by Application
6.1.1 Global DPU G.Fast Chipset Historical Sales by Application (2018-2023)
6.1.2 Global DPU G.Fast Chipset Forecasted Sales by Application (2024-2029)
6.1.3 Global DPU G.Fast Chipset Sales Market Share by Application (2018-2029)
6.2 Global DPU G.Fast Chipset Revenue by Application
6.2.1 Global DPU G.Fast Chipset Historical Revenue by Application (2018-2023)
6.2.2 Global DPU G.Fast Chipset Forecasted Revenue by Application (2024-2029)
6.2.3 Global DPU G.Fast Chipset Revenue Market Share by Application (2018-2029)
6.3 Global DPU G.Fast Chipset Price by Application
6.3.1 Global DPU G.Fast Chipset Price by Application (2018-2023)
6.3.2 Global DPU G.Fast Chipset Price Forecast by Application (2024-2029)
7 US & CANADA
7.1 US & Canada DPU G.Fast Chipset Market Size by Type
7.1.1 US & Canada DPU G.Fast Chipset Sales by Type (2018-2029)
7.1.2 US & Canada DPU G.Fast Chipset Revenue by Type (2018-2029)
7.2 US & Canada DPU G.Fast Chipset Market Size by Application
7.2.1 US & Canada DPU G.Fast Chipset Sales by Application (2018-2029)
7.2.2 US & Canada DPU G.Fast Chipset Revenue by Application (2018-2029)
7.3 US & Canada DPU G.Fast Chipset Sales by Country
7.3.1 US & Canada DPU G.Fast Chipset Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada DPU G.Fast Chipset Sales by Country (2018-2029)
7.3.3 US & Canada DPU G.Fast Chipset Revenue by Country (2018-2029)
7.3.4 U.S.
7.3.5 Canada
8 EUROPE
8.1 Europe DPU G.Fast Chipset Market Size by Type
8.1.1 Europe DPU G.Fast Chipset Sales by Type (2018-2029)
8.1.2 Europe DPU G.Fast Chipset Revenue by Type (2018-2029)
8.2 Europe DPU G.Fast Chipset Market Size by Application
8.2.1 Europe DPU G.Fast Chipset Sales by Application (2018-2029)
8.2.2 Europe DPU G.Fast Chipset Revenue by Application (2018-2029)
8.3 Europe DPU G.Fast Chipset Sales by Country
8.3.1 Europe DPU G.Fast Chipset Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe DPU G.Fast Chipset Sales by Country (2018-2029)
8.3.3 Europe DPU G.Fast Chipset Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 CHINA
9.1 China DPU G.Fast Chipset Market Size by Type
9.1.1 China DPU G.Fast Chipset Sales by Type (2018-2029)
9.1.2 China DPU G.Fast Chipset Revenue by Type (2018-2029)
9.2 China DPU G.Fast Chipset Market Size by Application
9.2.1 China DPU G.Fast Chipset Sales by Application (2018-2029)
9.2.2 China DPU G.Fast Chipset Revenue by Application (2018-2029)
10 ASIA (EXCLUDING CHINA)
10.1 Asia DPU G.Fast Chipset Market Size by Type
10.1.1 Asia DPU G.Fast Chipset Sales by Type (2018-2029)
10.1.2 Asia DPU G.Fast Chipset Revenue by Type (2018-2029)
10.2 Asia DPU G.Fast Chipset Market Size by Application
10.2.1 Asia DPU G.Fast Chipset Sales by Application (2018-2029)
10.2.2 Asia DPU G.Fast Chipset Revenue by Application (2018-2029)
10.3 Asia DPU G.Fast Chipset Sales by Region
10.3.1 Asia DPU G.Fast Chipset Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia DPU G.Fast Chipset Revenue by Region (2018-2029)
10.3.3 Asia DPU G.Fast Chipset Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 MIDDLE EAST, AFRICA AND LATIN AMERICA
11.1 Middle East, Africa and Latin America DPU G.Fast Chipset Market Size by Type
11.1.1 Middle East, Africa and Latin America DPU G.Fast Chipset Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America DPU G.Fast Chipset Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America DPU G.Fast Chipset Market Size by Application
11.2.1 Middle East, Africa and Latin America DPU G.Fast Chipset Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America DPU G.Fast Chipset Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America DPU G.Fast Chipset Sales by Country
11.3.1 Middle East, Africa and Latin America DPU G.Fast Chipset Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America DPU G.Fast Chipset Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America DPU G.Fast Chipset Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 CORPORATE PROFILES
12.1 Broadcom(US)
12.1.1 Broadcom(US) Company Information
12.1.2 Broadcom(US) Overview
12.1.3 Broadcom(US) DPU G.Fast Chipset Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Broadcom(US) DPU G.Fast Chipset Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Broadcom(US) Recent Developments
12.2 Sckipio Technology(Israel)
12.2.1 Sckipio Technology(Israel) Company Information
12.2.2 Sckipio Technology(Israel) Overview
12.2.3 Sckipio Technology(Israel) DPU G.Fast Chipset Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Sckipio Technology(Israel) DPU G.Fast Chipset Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Sckipio Technology(Israel) Recent Developments
12.3 Metanoia Communication(Taiwan)
12.3.1 Metanoia Communication(Taiwan) Company Information
12.3.2 Metanoia Communication(Taiwan) Overview
12.3.3 Metanoia Communication(Taiwan) DPU G.Fast Chipset Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Metanoia Communication(Taiwan) DPU G.Fast Chipset Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Metanoia Communication(Taiwan) Recent Developments
12.4 Qualcomm(US)
12.4.1 Qualcomm(US) Company Information
12.4.2 Qualcomm(US) Overview
12.4.3 Qualcomm(US) DPU G.Fast Chipset Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Qualcomm(US) DPU G.Fast Chipset Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Qualcomm(US) Recent Developments
13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
13.1 DPU G.Fast Chipset Industry Chain Analysis
13.2 DPU G.Fast Chipset Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 DPU G.Fast Chipset Production Mode & Process
13.4 DPU G.Fast Chipset Sales and Marketing
13.4.1 DPU G.Fast Chipset Sales Channels
13.4.2 DPU G.Fast Chipset Distributors
13.5 DPU G.Fast Chipset Customers
14 DPU G.FAST CHIPSET MARKET DYNAMICS
14.1 DPU G.Fast Chipset Industry Trends
14.2 DPU G.Fast Chipset Market Drivers
14.3 DPU G.Fast Chipset Market Challenges
14.4 DPU G.Fast Chipset Market Restraints
15 KEY FINDING IN THE GLOBAL DPU G.FAST CHIPSET STUDY
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
LIST OF TABLES
Table 1. Global AI Pharma Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Self-developed Oipeline
Table 3. Key Players of Contract Research Organization (CRO)
Table 4. Key Players of Other
Table 5. Global AI Pharma Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global AI Pharma Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global AI Pharma Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global AI Pharma Market Share by Region (2018-2023)
Table 9. Global AI Pharma Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global AI Pharma Market Share by Region (2024-2029)
Table 11. AI Pharma Market Trends
Table 12. AI Pharma Market Drivers
Table 13. AI Pharma Market Challenges
Table 14. AI Pharma Market Restraints
Table 15. Global AI Pharma Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global AI Pharma Market Share by Players (2018-2023)
Table 17. Global Top AI Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pharma as of 2022)
Table 18. Ranking of Global Top AI Pharma Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by AI Pharma Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players AI Pharma Product Solution and Service
Table 22. Date of Enter into AI Pharma Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global AI Pharma Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global AI Pharma Revenue Market Share by Type (2018-2023)
Table 26. Global AI Pharma Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global AI Pharma Revenue Market Share by Type (2024-2029)
Table 28. Global AI Pharma Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global AI Pharma Revenue Market Share by Application (2018-2023)
Table 30. Global AI Pharma Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global AI Pharma Revenue Market Share by Application (2024-2029)
Table 32. North America AI Pharma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America AI Pharma Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America AI Pharma Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe AI Pharma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe AI Pharma Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe AI Pharma Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific AI Pharma Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific AI Pharma Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific AI Pharma Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America AI Pharma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America AI Pharma Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America AI Pharma Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa AI Pharma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa AI Pharma Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa AI Pharma Market Size by Country (2024-2029) & (US$ Million)
Table 47. Recursion Company Detail
Table 48. Recursion Business Overview
Table 49. Recursion AI Pharma Product
Table 50. Recursion Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 51. Recursion Recent Development
Table 52. Insilico Medicine Company Detail
Table 53. Insilico Medicine Business Overview
Table 54. Insilico Medicine AI Pharma Product
Table 55. Insilico Medicine Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 56. Insilico Medicine Recent Development
Table 57. Exscientia Company Detail
Table 58. Exscientia Business Overview
Table 59. Exscientia AI Pharma Product
Table 60. Exscientia Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 61. Exscientia Recent Development
Table 62. BenevolentAI Company Detail
Table 63. BenevolentAI Business Overview
Table 64. BenevolentAI AI Pharma Product
Table 65. BenevolentAI Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 66. BenevolentAI Recent Development
Table 67. Atomwise Company Detail
Table 68. Atomwise Business Overview
Table 69. Atomwise AI Pharma Product
Table 70. Atomwise Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 71. Atomwise Recent Development
Table 72. Roivant Sciences Company Detail
Table 73. Roivant Sciences Business Overview
Table 74. Roivant Sciences AI Pharma Product
Table 75. Roivant Sciences Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 76. Roivant Sciences Recent Development
Table 77. Schrцdinger Company Detail
Table 78. Schrцdinger Business Overview
Table 79. Schrцdinger AI Pharma Product
Table 80. Schrцdinger Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 81. Schrцdinger Recent Development
Table 82. Lantern Pharma Company Detail
Table 83. Lantern Pharma Business Overview
Table 84. Lantern Pharma AI Pharma Product
Table 85. Lantern Pharma Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 86. Lantern Pharma Recent Development
Table 87. XtalPi Company Detail
Table 88. XtalPi Business Overview
Table 89. XtalPi AI Pharma Product
Table 90. XtalPi Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 91. XtalPi Recent Development
Table 92. Landos Biopharma Company Detail
Table 93. Landos Biopharma Business Overview
Table 94. Landos Biopharma AI Pharma Product
Table 95. Landos Biopharma Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 96. Landos Biopharma Recent Development
Table 97. Relay Therapeutics Company Detail
Table 98. Relay Therapeutics Business Overview
Table 99. Relay Therapeutics AI Pharma Product
Table 100. Relay Therapeutics Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 101. Relay Therapeutics Recent Development
Table 102. Accutar Biotech Company Detail
Table 103. Accutar Biotech Business Overview
Table 104. Accutar Biotech AI Pharma Product
Table 105. Accutar Biotech Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 106. Accutar Biotech Recent Development
Table 107. Deep Genomics Company Detail
Table 108. Deep Genomics Business Overview
Table 109. Deep Genomics AI Pharma Product
Table 110. Deep Genomics Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 111. Deep Genomics Recent Development
Table 112. Oncocross Company Detail
Table 113. Oncocross Business Overview
Table 114. Oncocross AI Pharma Product
Table 115. Oncocross Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 116. Oncocross Recent Development
Table 117. AI Therapeutics Company Detail
Table 118. AI Therapeutics Business Overview
Table 119. AI Therapeutics AI Pharma Product
Table 120. AI Therapeutics Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 121. AI Therapeutics Recent Development
Table 122. BioMap Company Detail
Table 123. BioMap Business Overview
Table 124. BioMap AI Pharma Product
Table 125. BioMap Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 126. BioMap Recent Development
Table 127. METiS Pharmaceuticals Company Detail
Table 128. METiS Pharmaceuticals Business Overview
Table 129. METiS Pharmaceuticals AI Pharma Product
Table 130. METiS Pharmaceuticals Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 131. METiS Pharmaceuticals Recent Development
Table 132. NeoX Biotech Company Detail
Table 133. NeoX Biotech Business Overview
Table 134. NeoX Biotech AI Pharma Product
Table 135. NeoX Biotech Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 136. NeoX Biotech Recent Development
Table 137. StoneWise Company Detail
Table 138. StoneWise Business Overview
Table 139. StoneWise AI Pharma Product
Table 140. StoneWise Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 141. StoneWise Recent Development
Table 142. Deep Intelligent Pharma Company Detail
Table 143. Deep Intelligent Pharma Business Overview
Table 144. Deep Intelligent Pharma AI Pharma Product
Table 145. Deep Intelligent Pharma Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 146. Deep Intelligent Pharma Recent Development
Table 147. Gigaceuticals Company Detail
Table 148. Gigaceuticals Business Overview
Table 149. Gigaceuticals AI Pharma Product
Table 150. Gigaceuticals Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 151. Gigaceuticals Recent Development
Table 152. Chemical.AI Company Detail
Table 153. Chemical.AI Business Overview
Table 154. Chemical.AI AI Pharma Product
Table 155. Chemical.AI Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 156. Chemical.AI Recent Development
Table 157. Artivila Company Detail
Table 158. Artivila Business Overview
Table 159. Artivila AI Pharma Product
Table 160. Artivila Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 161. Artivila Recent Development
Table 162. Galixir Company Detail
Table 163. Galixir Business Overview
Table 164. Galixir AI Pharma Product
Table 165. Galixir Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 166. Galixir Recent Development
Table 167. Xbiome Company Detail
Table 168. Xbiome Business Overview
Table 169. Xbiome AI Pharma Product
Table 170. Xbiome Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 171. Xbiome Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
Table 1. Global AI Pharma Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Self-developed Oipeline
Table 3. Key Players of Contract Research Organization (CRO)
Table 4. Key Players of Other
Table 5. Global AI Pharma Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global AI Pharma Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global AI Pharma Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global AI Pharma Market Share by Region (2018-2023)
Table 9. Global AI Pharma Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global AI Pharma Market Share by Region (2024-2029)
Table 11. AI Pharma Market Trends
Table 12. AI Pharma Market Drivers
Table 13. AI Pharma Market Challenges
Table 14. AI Pharma Market Restraints
Table 15. Global AI Pharma Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global AI Pharma Market Share by Players (2018-2023)
Table 17. Global Top AI Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pharma as of 2022)
Table 18. Ranking of Global Top AI Pharma Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by AI Pharma Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players AI Pharma Product Solution and Service
Table 22. Date of Enter into AI Pharma Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global AI Pharma Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global AI Pharma Revenue Market Share by Type (2018-2023)
Table 26. Global AI Pharma Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global AI Pharma Revenue Market Share by Type (2024-2029)
Table 28. Global AI Pharma Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global AI Pharma Revenue Market Share by Application (2018-2023)
Table 30. Global AI Pharma Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global AI Pharma Revenue Market Share by Application (2024-2029)
Table 32. North America AI Pharma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America AI Pharma Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America AI Pharma Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe AI Pharma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe AI Pharma Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe AI Pharma Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific AI Pharma Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific AI Pharma Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific AI Pharma Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America AI Pharma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America AI Pharma Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America AI Pharma Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa AI Pharma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa AI Pharma Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa AI Pharma Market Size by Country (2024-2029) & (US$ Million)
Table 47. Recursion Company Detail
Table 48. Recursion Business Overview
Table 49. Recursion AI Pharma Product
Table 50. Recursion Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 51. Recursion Recent Development
Table 52. Insilico Medicine Company Detail
Table 53. Insilico Medicine Business Overview
Table 54. Insilico Medicine AI Pharma Product
Table 55. Insilico Medicine Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 56. Insilico Medicine Recent Development
Table 57. Exscientia Company Detail
Table 58. Exscientia Business Overview
Table 59. Exscientia AI Pharma Product
Table 60. Exscientia Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 61. Exscientia Recent Development
Table 62. BenevolentAI Company Detail
Table 63. BenevolentAI Business Overview
Table 64. BenevolentAI AI Pharma Product
Table 65. BenevolentAI Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 66. BenevolentAI Recent Development
Table 67. Atomwise Company Detail
Table 68. Atomwise Business Overview
Table 69. Atomwise AI Pharma Product
Table 70. Atomwise Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 71. Atomwise Recent Development
Table 72. Roivant Sciences Company Detail
Table 73. Roivant Sciences Business Overview
Table 74. Roivant Sciences AI Pharma Product
Table 75. Roivant Sciences Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 76. Roivant Sciences Recent Development
Table 77. Schrцdinger Company Detail
Table 78. Schrцdinger Business Overview
Table 79. Schrцdinger AI Pharma Product
Table 80. Schrцdinger Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 81. Schrцdinger Recent Development
Table 82. Lantern Pharma Company Detail
Table 83. Lantern Pharma Business Overview
Table 84. Lantern Pharma AI Pharma Product
Table 85. Lantern Pharma Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 86. Lantern Pharma Recent Development
Table 87. XtalPi Company Detail
Table 88. XtalPi Business Overview
Table 89. XtalPi AI Pharma Product
Table 90. XtalPi Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 91. XtalPi Recent Development
Table 92. Landos Biopharma Company Detail
Table 93. Landos Biopharma Business Overview
Table 94. Landos Biopharma AI Pharma Product
Table 95. Landos Biopharma Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 96. Landos Biopharma Recent Development
Table 97. Relay Therapeutics Company Detail
Table 98. Relay Therapeutics Business Overview
Table 99. Relay Therapeutics AI Pharma Product
Table 100. Relay Therapeutics Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 101. Relay Therapeutics Recent Development
Table 102. Accutar Biotech Company Detail
Table 103. Accutar Biotech Business Overview
Table 104. Accutar Biotech AI Pharma Product
Table 105. Accutar Biotech Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 106. Accutar Biotech Recent Development
Table 107. Deep Genomics Company Detail
Table 108. Deep Genomics Business Overview
Table 109. Deep Genomics AI Pharma Product
Table 110. Deep Genomics Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 111. Deep Genomics Recent Development
Table 112. Oncocross Company Detail
Table 113. Oncocross Business Overview
Table 114. Oncocross AI Pharma Product
Table 115. Oncocross Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 116. Oncocross Recent Development
Table 117. AI Therapeutics Company Detail
Table 118. AI Therapeutics Business Overview
Table 119. AI Therapeutics AI Pharma Product
Table 120. AI Therapeutics Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 121. AI Therapeutics Recent Development
Table 122. BioMap Company Detail
Table 123. BioMap Business Overview
Table 124. BioMap AI Pharma Product
Table 125. BioMap Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 126. BioMap Recent Development
Table 127. METiS Pharmaceuticals Company Detail
Table 128. METiS Pharmaceuticals Business Overview
Table 129. METiS Pharmaceuticals AI Pharma Product
Table 130. METiS Pharmaceuticals Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 131. METiS Pharmaceuticals Recent Development
Table 132. NeoX Biotech Company Detail
Table 133. NeoX Biotech Business Overview
Table 134. NeoX Biotech AI Pharma Product
Table 135. NeoX Biotech Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 136. NeoX Biotech Recent Development
Table 137. StoneWise Company Detail
Table 138. StoneWise Business Overview
Table 139. StoneWise AI Pharma Product
Table 140. StoneWise Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 141. StoneWise Recent Development
Table 142. Deep Intelligent Pharma Company Detail
Table 143. Deep Intelligent Pharma Business Overview
Table 144. Deep Intelligent Pharma AI Pharma Product
Table 145. Deep Intelligent Pharma Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 146. Deep Intelligent Pharma Recent Development
Table 147. Gigaceuticals Company Detail
Table 148. Gigaceuticals Business Overview
Table 149. Gigaceuticals AI Pharma Product
Table 150. Gigaceuticals Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 151. Gigaceuticals Recent Development
Table 152. Chemical.AI Company Detail
Table 153. Chemical.AI Business Overview
Table 154. Chemical.AI AI Pharma Product
Table 155. Chemical.AI Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 156. Chemical.AI Recent Development
Table 157. Artivila Company Detail
Table 158. Artivila Business Overview
Table 159. Artivila AI Pharma Product
Table 160. Artivila Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 161. Artivila Recent Development
Table 162. Galixir Company Detail
Table 163. Galixir Business Overview
Table 164. Galixir AI Pharma Product
Table 165. Galixir Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 166. Galixir Recent Development
Table 167. Xbiome Company Detail
Table 168. Xbiome Business Overview
Table 169. Xbiome AI Pharma Product
Table 170. Xbiome Revenue in AI Pharma Business (2018-2023) & (US$ Million)
Table 171. Xbiome Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global AI Pharma Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global AI Pharma Market Share by Type: 2022 VS 2029
Figure 3. Self-developed Oipeline Features
Figure 4. Contract Research Organization (CRO) Features
Figure 5. Other Features
Figure 6. Global AI Pharma Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global AI Pharma Market Share by Application: 2022 VS 2029
Figure 8. Preclinical Stage (Optimization of Lead Compounds, etc.) Case Studies
Figure 9. Clinical Trial Phase (Predicting Treatment Outcome, etc.) Case Studies
Figure 10. AI Pharma Report Years Considered
Figure 11. Global AI Pharma Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global AI Pharma Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global AI Pharma Market Share by Region: 2022 VS 2029
Figure 14. Global AI Pharma Market Share by Players in 2022
Figure 15. Global Top AI Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pharma as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by AI Pharma Revenue in 2022
Figure 17. North America AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America AI Pharma Market Share by Country (2018-2029)
Figure 19. United States AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe AI Pharma Market Share by Country (2018-2029)
Figure 23. Germany AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific AI Pharma Market Share by Region (2018-2029)
Figure 31. China AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America AI Pharma Market Share by Country (2018-2029)
Figure 39. Mexico AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa AI Pharma Market Share by Country (2018-2029)
Figure 43. Turkey AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Recursion Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 46. Insilico Medicine Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 47. Exscientia Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 48. BenevolentAI Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 49. Atomwise Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 50. Roivant Sciences Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 51. Schrцdinger Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 52. Lantern Pharma Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 53. XtalPi Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 54. Landos Biopharma Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 55. Relay Therapeutics Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 56. Accutar Biotech Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 57. Deep Genomics Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 58. Oncocross Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 59. AI Therapeutics Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 60. BioMap Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 61. METiS Pharmaceuticals Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 62. NeoX Biotech Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 63. StoneWise Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 64. Deep Intelligent Pharma Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 65. Gigaceuticals Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 66. Chemical.AI Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 67. Artivila Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 68. Galixir Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 69. Xbiome Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Figure 1. Global AI Pharma Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global AI Pharma Market Share by Type: 2022 VS 2029
Figure 3. Self-developed Oipeline Features
Figure 4. Contract Research Organization (CRO) Features
Figure 5. Other Features
Figure 6. Global AI Pharma Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global AI Pharma Market Share by Application: 2022 VS 2029
Figure 8. Preclinical Stage (Optimization of Lead Compounds, etc.) Case Studies
Figure 9. Clinical Trial Phase (Predicting Treatment Outcome, etc.) Case Studies
Figure 10. AI Pharma Report Years Considered
Figure 11. Global AI Pharma Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global AI Pharma Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global AI Pharma Market Share by Region: 2022 VS 2029
Figure 14. Global AI Pharma Market Share by Players in 2022
Figure 15. Global Top AI Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pharma as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by AI Pharma Revenue in 2022
Figure 17. North America AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America AI Pharma Market Share by Country (2018-2029)
Figure 19. United States AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe AI Pharma Market Share by Country (2018-2029)
Figure 23. Germany AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific AI Pharma Market Share by Region (2018-2029)
Figure 31. China AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America AI Pharma Market Share by Country (2018-2029)
Figure 39. Mexico AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa AI Pharma Market Share by Country (2018-2029)
Figure 43. Turkey AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia AI Pharma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Recursion Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 46. Insilico Medicine Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 47. Exscientia Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 48. BenevolentAI Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 49. Atomwise Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 50. Roivant Sciences Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 51. Schrцdinger Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 52. Lantern Pharma Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 53. XtalPi Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 54. Landos Biopharma Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 55. Relay Therapeutics Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 56. Accutar Biotech Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 57. Deep Genomics Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 58. Oncocross Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 59. AI Therapeutics Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 60. BioMap Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 61. METiS Pharmaceuticals Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 62. NeoX Biotech Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 63. StoneWise Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 64. Deep Intelligent Pharma Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 65. Gigaceuticals Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 66. Chemical.AI Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 67. Artivila Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 68. Galixir Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 69. Xbiome Revenue Growth Rate in AI Pharma Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
